Homocisteina y riñón: revisión bibliográfica
Herra Sánchez, Sergio A.
Rev. méd. Costa Rica Centroam
; 66(547): 59-63, abr.-jun. 1999.
Artículo en Español | LILACS | ID: lil-257256
Documentos relacionados
Protein intake, chronic renal disease progression and cardiovascular morbidity.
Role of ferroptosis in chronic kidney disease.
Prognostic Models in Nephrology: Where Do We Stand and Where Do We Go from Here? Mapping Out the Evidence in a Scoping Review.
Global perspective of kidney diseases: Challenges and changes.
Predicting outcomes in chronic kidney disease: needs and preferences of patients and nephrologists.
Health-related Quality of Life in 10 years Long-term Survivors of Chronic Kidney Disease: A From-J Study.
Multitargeted Internal Calibration for the Quantification of Chronic Kidney Disease-Related Endogenous Metabolites Using Liquid Chromatography-Mass Spectrometry.
Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease.
AHA Life's Essential 8 and new-onset CKD: a prospective cohort study from the UK Biobank.
The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy.